Recombinant antibodies offer significant benefits compared to traditional hybridoma-produced monoclonal antibodies, including ensuring bath-to-batch reproducibility and enabling antibody engineering. Antibody engineering allows researchers to improve experimental design and develop complex controls with absolute precision.
In this presentation, Dr. Michael Fiebig outlines the advantages of recombinant antibodies. He illustrates these benefits with examples from Absolute Antibody’s recombinant antibody catalog, including VivopureX™ mouse-anti-mouse antibodies for in vivo research and engineered coronavirus antibodies for COVID-19 diagnostic tests. Please enter your contact information below to view the video.